HIV Diagnostics Market Size & Growth Forecast 2026–2035, By Segments (Mode, Product, End Use, Test Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
HIV Diagnostics Market size was over USD 1.14 Billion in 2025 and is likely to grow at a 5.6% CAGR between 2026 and 2035, reaching USD 1.97 Billion by 2035. The industry revenue for 2026 is calculated at USD 1.19 billion.
Get more details on this report
Request Free Sample ReportHIV Diagnostics Market Intelligence Snapshot
Regional Market Dynamics
- North America led with a 29.05% share in 2025, supported by established screening programs, laboratory infrastructure, reimbursement pathways, and advanced diagnostic technology adoption.
- Asia Pacific is projected to grow at a 6.33% CAGR, driven by expanding healthcare access, stronger screening initiatives, and wider adoption of scalable diagnostic solutions.
Segment Momentum
- Lab-based testing held an 88.26% share in 2025 due to its role in confirmatory testing, established clinical workflows, and compatibility with high-volume testing, reporting, and procurement systems across formal healthcare settings.
- Software and Services are the fastest-growing product segment as testing programs increasingly require data management, workflow coordination, reporting integration, and operational support across expanding diagnostic networks.
Market Expansion Drivers
- Rising global HIV burden increasing demand for early detection and routine screening programs.
- Expansion of point-of-care and rapid diagnostic testing improving access in low-resource regions.
- Government-led awareness and testing initiatives driving widespread voluntary HIV screening adoption.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Major companies in the HIV diagnostics market include Abbott Laboratories (United States), F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers AG (Germany), QIAGEN N.V. (Netherlands), Becton, Dickinson and Company (United States), Beckman Coulter, Inc. (United States), bioMérieux SA (France), Sysmex Corporation (Japan), OraSure Technologies, Inc. (United States), Danaher Corporation (United States).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
As the number of people requiring diagnosis, linkage to care, and ongoing status monitoring increases, healthcare systems are placing greater emphasis on identifying infections earlier and expanding routine screening beyond high-risk or symptomatic populations. This is driving demand for the HIV diagnostics market through higher test volumes in hospitals, public health laboratories, sexual health clinics, antenatal programs, and community screening settings. Early detection has practical importance because delayed diagnosis raises transmission risk and postpones treatment initiation, so providers and health agencies increasingly integrate HIV testing into standard care pathways, reinforcing market demand for laboratory assays, confirmatory tests, and screening platforms that can support repeat and large-scale testing.
Expansion of point-of-care and rapid diagnostic testing improving access in low-resource regions
Broader availability of point-of-care and rapid tests is reshaping purchasing and deployment patterns in the HIV diagnostics market by making testing feasible in settings where centralized laboratory infrastructure is limited or inconsistent. Health systems, NGOs, and frontline care providers can deliver screening in rural clinics, mobile outreach programs, pharmacies, and community campaigns without depending on complex equipment or long sample transport times. That practical shift increases market penetration by reducing loss to follow-up, shortening the time between testing and counseling, and enabling decentralized procurement models that favor easy-to-use, portable diagnostic formats tailored to low-resource environments.
Government-led awareness and testing initiatives driving widespread voluntary HIV screening adoption
Public-sector awareness campaigns and organized testing initiatives are influencing adoption in the HIV diagnostics market by normalizing voluntary screening and embedding it into national prevention and treatment strategies. When governments fund campaigns, set testing targets, expand free or subsidized access, and integrate HIV tests into public health programs, screening moves from episodic demand to a more structured and recurring service. This strengthens market development by creating predictable procurement from public hospitals, diagnostic centers, and outreach networks while also increasing patient willingness to seek testing through reduced stigma and stronger awareness of the value of knowing HIV status early.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising global HIV burden increasing demand for early detection and routine screening programs | 2.00% | High | Africa, North America, Asia Pacific | High | Near Term |
| Expansion of point-of-care and rapid diagnostic testing improving access in low-resource regions | 1.80% | High | Africa, Asia Pacific, Latin America | High | Mid Term |
| Government-led awareness and testing initiatives driving widespread voluntary HIV screening adoption | 1.50% | High | North America, Europe, Asia Pacific | High | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held a 29.05% share of the HIV diagnostics market in 2025, backed by established screening programs, broad access to laboratory infrastructure, and consistent testing demand across hospitals, diagnostic centers, and public health networks. The region’s leadership is reinforced by routine HIV testing integration into clinical care, higher awareness levels, and stronger reimbursement pathways that help sustain test volumes in practice. Market activity also benefits from the availability of advanced diagnostic technologies and well-developed procurement systems, which support steady adoption across both centralized and point-of-care settings.
Asia Pacific is projected to expand at a 6.33% CAGR over the forecast period in the HIV diagnostics market, driven by rising testing access, expanding healthcare infrastructure, and wider adoption of early detection initiatives across diverse care settings. Growth is accelerating as more countries strengthen public health screening efforts and extend diagnostic availability beyond major urban centers, increasing the practical reach of testing services. The region is also seeing stronger uptake as healthcare systems improve laboratory capacity and support broader use of affordable and scalable diagnostic solutions.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
High-Accuracy DiagnosticsGermany prioritizes HIV diagnostics with strong analytical performance and compatibility with modern laboratory systems. Healthcare providers emphasize standardized testing protocols and reliable assay quality to support consistent clinical decision-making.
France 🇫🇷
Preventive Testing ProgramsFrance emphasizes HIV diagnostics that complement preventive healthcare initiatives and routine screening services. Diagnostic suppliers support healthcare providers with accurate testing solutions designed for efficient integration into public and clinical health programs.
Italy 🇮🇹
Accessible Clinical DiagnosticsItaly's HIV diagnostics market prioritizes dependable testing technologies that improve accessibility across hospitals and diagnostic laboratories. Healthcare institutions increasingly adopt streamlined diagnostic workflows that support earlier confirmation and effective patient care coordination.
Japan 🇯🇵
Routine Screening IntegrationJapan emphasizes HIV diagnostics that support routine screening through reliable laboratory platforms and efficient clinical workflows. Diagnostic manufacturers continue refining assay performance while improving usability across hospitals and specialized healthcare facilities.
South Korea 🇰🇷
Rapid Testing ExpansionSouth Korea advances HIV diagnostics through broader availability of rapid testing technologies alongside centralized laboratory services. Healthcare organizations focus on efficient diagnosis and accessible testing pathways that enhance overall clinical responsiveness.
United States 🇺🇸
Comprehensive Testing AccessThe U.S. HIV diagnostics market focuses on expanding access to laboratory-based and point-of-care testing across diverse healthcare settings. Diagnostic providers emphasize rapid result delivery, workflow integration, and technologies that support routine screening and ongoing patient management.
Segment Leadership and Growth Trends
HIV Diagnostics Market Share (%), Mode, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportWithin the HIV diagnostics market, lab-based testing held the dominant position in 2025 with an 88.26% share. its position is underpinned by the routine use of laboratory infrastructure for confirmatory testing, established clinical workflows, and the need for standardized processing in hospitals, diagnostic centers, and public health programs. Lab-based methods remain deeply embedded in the HIV diagnostics market because they support higher-volume testing environments and fit procurement and reporting systems already used across formal care settings.
Self-test is the fastest-growing mode in the HIV diagnostics market as demand rises for more accessible and private testing options outside conventional care environments. Growth is being reinforced through practical use cases where convenience, discretion, and easier first-step screening matter more than centralized testing access. Compared with lab-based pathways, self-test is gaining momentum because it lowers the access barrier for individuals who may delay or avoid facility-based testing, making it a more responsive option for broader screening outreach.
Product Segment Analysis: Consumables (Largest Segment) vs Software and Services (Fastest-Growing Segment)
Consumables accounted for the largest position in the HIV diagnostics market in 2025, capturing a 52.47% share. This segment remains dominant because diagnostic testing depends on recurring use of kits, reagents, cartridges, and related materials across every testing cycle. The steady throughput of screening and confirmatory procedures keeps consumables central to the HIV diagnostics market, as each test performed directly translates into repeat product demand across laboratories and point-of-care settings.
Software and Services represent the fastest-growing product segment in the HIV diagnostics market as testing operations increasingly depend on data handling, workflow coordination, and result management. Their momentum is tied to the practical need to connect diagnostic activity with reporting systems, quality oversight, and service support rather than relying only on physical test components. Relative to consumables, this segment is expanding faster because digital integration and ongoing service requirements become more important as testing networks scale and operational complexity increases.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Mode | Self-test, Lab-based | Lab-based | Self-test |
| Product | Consumables, Instruments, Software and Services | Consumables | Software and Services |
| End Use | Diagnostic Laboratories, Hospitals & Clinics, Home Settings | Diagnostic Laboratories | Home Settings |
| Test Type | Antibody Test, Viral Load Test, CD4 Test, Others | Antibody Test | Antibody Test |
Competitive Landscape and Market Positioning
1. Abbott Laboratories (United States)
2. F. Hoffmann-La Roche Ltd. (Switzerland)
3. Siemens Healthineers AG (Germany)
4. QIAGEN N.V. (Netherlands)
5. Becton Dickinson and Company (United States)
6. Beckman Coulter Inc. (United States)
7. bioMérieux SA (France)
8. Sysmex Corporation (Japan)
9. OraSure Technologies Inc. (United States)
10. Danaher Corporation (United States)
The HIV diagnostics market is being shaped by rising demand for rapid, accessible, and highly sensitive testing solutions. Companies are investing in next-generation diagnostic platforms that improve detection accuracy and reduce turnaround times across healthcare settings. Expansion of portable and decentralized testing technologies is also supporting broader market growth.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| bioMérieux | Jun-25 | bioMérieux signed a definitive agreement to acquire the core assets of US-based Day Zero Diagnostics, including its proprietary next-generation sequencing workflows, reagents, and bioinformatics software. This acquisition enhances bioMérieux's precision diagnostics portfolio and accelerates its capabilities in rapid testing innovation. |
| Abbott | Dec-24 | Abbott established a strategic healthcare access partnership in Nigeria alongside Siemens Healthineers AG, Abbott Laboratories GmbH, and local partner Tanit Medical Engineering. The collaborative agreement focuses on strengthening domestic healthcare infrastructure and improving regional deployment of diagnostic services. |
| OraSure Technologies | Jan-25 | OraSure Technologies secured US FDA approval for a labeling update to its OraQuick HIV Self-Test, lowering the authorized user age from 17 to 14 years old. This regulatory expansion broadens the product's addressable adolescent market segment and enhances early-detection testing access. |
| MedMira | Jan-25 | MedMira received regulatory approval from Health Canada for its RevealRapid G4 Test, a rapid point-of-care HIV-1/2 antibody diagnostic that delivers results within seconds. The approval introduces high-velocity testing efficiencies into Canadian clinical and point-of-care settings. |
| Lord’s Mark | May-26 | Lord’s Mark secured inclusion into a select group of nine globally recognized organizations in the HIV self-testing segment. This recognition elevates the company's competitive standing within the expanding international market for accessible, consumer-facing HIV diagnostic kits. |
| Cepheid | Apr-24 | Cepheid obtained World Health Organization prequalification for its Xpert HIV-1 Qual XC point-of-care diagnostic test. The certification validates the test's performance standards for early infant HIV detection and broadens international procurement opportunities using dried blood spots. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
HIV Diagnostics Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
HIV Diagnostics Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of HIV diagnostics?
What are the growth projections for the HIV diagnostics industry?
How are routine screening programs influencing demand in the HIV diagnostics market?
Why are point-of-care HIV diagnostics becoming a strategic investment priority?
Why does lab-based testing dominate the HIV diagnostics market?
Which product segment is growing fastest in the HIV diagnostics market?
Why does North America lead the HIV diagnostics market?
How is Asia Pacific driving future growth in HIV diagnostics?
Which companies dominate the HIV diagnostics landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization